The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for ...

The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.

EXETER, UK — Patients with supraventricular tachycardia (SVT) treated with a modified Valsalva maneuver are nearly four times more likely to return to normal sinus rhythm than individuals treated with ...

CARDAMYST nasal spray is a novel and rapid-acting calcium channel blocker delivered when needed to treat often highly ...

Please provide your email address to receive an email when new articles are posted on . Etripamil, a novel fast-acting calcium channel blocker administered via nasal spray, was not superior to placebo ...

DENVER — Heart disease in young people is certainly possible. Supraventricular tachycardia (SVT) can affect kids, adolescents and young adults. It occurs in about 2 out of every 1,000 people. SVT ...

CHICAGO — A fast-acting nasal spray safely and effectively converted episodes of paroxysmal supraventricular tachycardia to normal sinus rhythm with a significant reduction in ED utilization and ...

MONTREAL and CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...

The mom of three has supraventricular tachycardia, which results in an abnormally rapid heart rhythm Gil and Kelly Bates are asking for prayers as their daughter undergoes her second heart surgery ...